Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511797
Status:
COMPLETED
Last Update Posted:
2017-01-26
First Post:
2007-08-03
Brief Title:
SH T00186 Phase II III Optimal Drospirenone DRSP Dose Finding and Placebo-controlled Comparative Study
Sponsor:
Bayer
Organization:
Bayer